South Dakota Investment Council Merck & Co., Inc. Transaction History

South Dakota Investment Council

$4.88 Billion
Q2 2024

A detailed history of South Dakota Investment Council transactions in Merck & Co., Inc. stock. As of the latest transaction made, South Dakota Investment Council holds 210,886 shares of MRK stock, worth $24 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

210,886

Previous 233,232 9.58%

Holding current value

$24 Million

Previous $30.8 Million 15.16%

% of portfolio

0.54%

Previous 0.64%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$123.8 - $132.96 $2.77 Million - $2.97 Million	-22,346 Reduced 9.58%	210,886 $26.1 Million
Q1 2024 May 02, 2024	SELL	$113.24 - $131.95 $2.13 Million - $2.48 Million	-18,800 Reduced 7.46%	233,232 $30.8 Million
Q4 2023 Feb 01, 2024	BUY	$100.18 - $109.02 $380,082 - $413,621	3,794 Added 1.53%	252,032 $27.5 Million
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $2.1 Million - $2.33 Million	-20,408 Reduced 7.6%	248,238 $25.6 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $3.45 Million - $3.76 Million	-31,773 Reduced 10.58%	268,646 $31 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $3.55 Million - $3.96 Million	-34,520 Reduced 10.31%	300,419 $32 Million
Q4 2022 Feb 07, 2023	SELL	$87.44 - $112.11 $5.48 Million - $7.03 Million	-62,663 Reduced 15.76%	334,939 $37.2 Million
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $1.33 Million - $1.5 Million	-15,764 Reduced 3.81%	397,602 $34.2 Million
Q2 2022 Aug 11, 2022	SELL	$83.49 - $94.64 $377,875 - $428,340	-4,526 Reduced 1.08%	413,366 $37.7 Million
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $7.64 Million - $8.56 Million	-103,890 Reduced 19.91%	417,892 $34.3 Million
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $1.32 Million - $1.65 Million	18,250 Added 3.62%	521,782 $40 Million
Q3 2021 Nov 09, 2021	BUY	$71.68 - $78.83 $3.47 Million - $3.81 Million	48,340 Added 10.62%	503,532 $37.8 Million
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $1.92 Million - $2.12 Million	-27,290 Reduced 5.66%	455,192 $35.4 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $5.31 Million - $6.26 Million	77,159 Added 19.04%	482,482 $37.2 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $5.3 Million - $5.88 Million	73,820 Added 22.27%	405,323 $33.2 Million
Q3 2020 Nov 06, 2020	BUY	$73.18 - $82.95 $854,010 - $968,026	11,670 Added 3.65%	331,503 $27.5 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $5.66 Million - $6.44 Million	80,410 Added 33.58%	319,833 $24.7 Million
Q1 2020 May 11, 2020	SELL	$63.36 - $87.82 $77,235 - $107,052	-1,219 Reduced 0.51%	239,423 $18.4 Million
Q4 2019 Feb 11, 2020	SELL	$77.58 - $87.54 $5.05 Million - $5.7 Million	-65,100 Reduced 21.29%	240,642 $21.9 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $473,978 - $516,653	-6,230 Reduced 2.0%	305,742 $25.7 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $7.01 Million - $8.19 Million	-100,350 Reduced 24.34%	311,972 $26.2 Million
Q1 2019 May 03, 2019	SELL	$69.58 - $79.36 $1.93 Million - $2.2 Million	-27,770 Reduced 6.31%	412,322 $34.3 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $5.91 Million - $6.95 Million	-102,380 Reduced 18.87%	440,092 $31.2 Million
Q2 2018 Aug 13, 2018	SELL	$50.83 - $59.72 $98,101 - $115,259	-1,930 Reduced 0.35%	542,472 $32.9 Million
Q1 2018 May 10, 2018	BUY	$50.96 - $59.23 $6.9 Million - $8.02 Million	135,392 Added 33.1%	544,402 $29.7 Million
Q4 2017 Feb 09, 2018	BUY	$51.62 - $61.64 $14.7 Million - $17.6 Million	285,410 Added 230.91%	409,010 $23 Million
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $7.25 Million - $7.8 Million	123,600	123,600 $7.91 Million

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.

Account

South Dakota Investment Council Merck & Co., Inc. Transaction History